At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Nonablative Fractional Diode Laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of a Nonablative Fractional 1940 nm Diode Laser for Skin Resurfacing and Treatment of Pigmented Lesions
In Brief
A clinical study evaluating Nonablative Fractional Diode Laser for Skin Texture and Pigmented Lesions. Completed, enrolled 26 participants across 1 site.
Detailed Summary
This study is intended to evaluate the efficacy and safety of a new diode fractional laser for skin resurfacing and treatment of pigmented lesions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Texture, Pigmented Lesions
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartSep 2019
First PostedDec 2019
Primary CompletionApr 2021
Study CompletionAug 2021
TodayJul 2026
First PostedDec 18, 2019
Enrollment StartSep 18, 2019
Primary CompletionApr 30, 2021
Study CompletionAug 5, 2021
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 6.5 years ago
Interventions
Nonablative Fractional Diode Laserdevice
The FRAX 1940 is a fractional 1940 nm solid-state diode laser that delivers linear arrays of microbeams to create nonablative microscopic treatment zones (MTZs) in the skin.